HIGHLIGHTS
- who: Hu Li et al. from the United States Shanghai Jiao Tong University, China have published the Article: Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug, in the Journal: (JOURNAL)
- what: The main reason for the above mechanism is that the proportion of Smad7/ Smad3 is up-regulated, which inhibits the TGFb-mediated MET process .
- how: The above data showed that TsIIA induced HCC apoptosis in part through the calcium-dependent apoptosis pathway . Previous laboratory data showed that the expression level of E-cadherin in HCC cells treated with TsIIA was increased . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.